Intragam P Solution for infusion

Intragam P Solution for infusion is a brand of medicine containing the active ingredient immunoglobulin, normal (human).

Find out more about active ingredients.

Consumer medicine information (CMI) leaflet

Developed by the pharmaceutical company responsible for this medicine in Australia, according to TGA regulations.

Intragam® P

Human Normal Immunoglobulin, solution for intravenous infusion

Consumer Medicine Information

What is in this leaflet

This leaflet answers some common questions about Intragam® P. It does not contain complete information about Intragam® P. It does not take the place of talking to your doctor.

If you have any concerns about using this medicine, ask your doctor. Follow your doctor’s advice even if it is different from what this leaflet says.

Please read this leaflet carefully and keep it for future reference.

The information in this leaflet is subject to change. Please check with your doctor whether there is any new information about this medicine that you should know since you were last treated.

Back to top

What Intragam® P is used for

Intragam® P is manufactured from human plasma (the liquid component of blood) collected by the Australian Red Cross Blood Service. Intragam® P is used for patients who need replacement of antibodies which form part of our immune system and can provide protection against some infections. Intragam® P is also used in diseases when the immune system is overactive, these are called autoimmune disorders.

Ask your doctor if you have any questions about why Intragam® P has been prescribed for you. Your doctor will have assessed the risks and benefits for you associated with the use of this medicine.

Back to top

Before you are given Intragam® P

Intragam® P must not be used if you have a history of allergy to human immunoglobulin products. Tell your doctor if you have allergies to any other medicines, or if you have ever had an allergic reaction to an injection.

Tell your doctor also if you:

  • have previously been advised that you have Immunoglobulin A (IgA) deficiency
  • have previously been advised that you have kidney disease
  • have a previous history of clotting in blood vessels (thrombosis)
  • have previously been treated with immunoglobulin products
  • have previously been advised that you have diabetes
  • are taking or using any other medicines. These include medicines bought from pharmacies, supermarkets and health food stores.
  • have any other medical conditions
  • are pregnant or breast-feeding
  • become pregnant during your treatment
  • have had any vaccination within the last two weeks or intend to receive one in the next three months.

If you want further information, consult your doctor.

Back to top

How to use Intragam® P

Your doctor will determine the dose(s) of Intragam® P that you will receive. Your doctor will give you Intragam® P as an infusion, that is, an injection given slowly into the vein.

Back to top

Side effects

Along with their intended effects, blood products occasionally cause unwanted effects, some of which are serious. Unwanted effects are more common with the first dose of Intragam® P. Individuals may react differently to similar doses of the same product. This applies to Intragam® P. Most minor effects are related to the rate of infusion and disappear when the rate is slowed down.

Effects associated with Intragam® P

During a clinical trial with Intragam® P in patients who needed replacement of antibodies, some patients experienced headache, migraine, nausea, dizziness or faintness, and tiredness. Reduced red blood cells and iron stores and reduced white blood cells were also reported.

During another clinical trial with Intragam® P in patients with an overactive immune system, who received larger doses of Intragam® P, some patients experienced headache, nausea, vomiting, shivering, fever, drowsiness, hot flushes, muscle pain, abdominal pain, allergic reactions, reddening of the face or neck, a hot feeling or redness at the site of the injection and increased blood pressure. Reduced red and white blood cells were also reported.

Effects associated with similar products

Unwanted effects which may occur include stomach pain, headache, chest tightness, flushed or pale face, feeling hot or unwell, shortness of breath or breathing difficulty, skin rash, itching, general redness, swelling, faintness, dizziness, nausea or vomiting or a hot feeling or redness at the site of the injection. Should any of these effects develop during infusion, the doctor will take appropriate action.

Some patients may develop delayed unwanted effects such as nausea, vomiting, chest pain, chills or shivering, dizziness, aching legs or joint pain. These effects may occur after the infusion has stopped but usually within 24 hours.

A condition called aseptic meningitis syndrome has been reported to occur infrequently in association with infusions similar to Intragam® P. It usually begins within several hours to two days following treatment. The signs include severe headache, neck stiffness, drowsiness, fever, inability to stand bright light, painful eye movements, and nausea and vomiting. The condition reverses without ill effects when treatment is stopped.

There have been reports that the kidneys, liver and blood vessels (thrombosis) may be affected with infusions similar to Intragam® P. These occurrences are extremely rare.

If you experience any of the mentioned effects or any other abnormal signs after treatment, contact your doctor immediately.

Contact your doctor immediately if you experience any of these symptoms at any time: fever, loss of appetite, extreme tiredness, stomach pain, jaundice (yellow skin and eyes), dark urine, joint pain and skin rashes.

Intragam® P can interfere with some live vaccines (e.g. measles and polio), even up to three months later. Advise your doctor if you are to receive other vaccines within three months of receiving Intragam® P.

About blood products

This product is made from human plasma obtained from voluntary donors. When products are made from human blood and injected into you, it is possible that viruses or other substances could be present in the product and cause an illness. These could be viruses such as hepatitis, human immunodeficiency virus (HIV), or parvovirus B19 and theoretically the Creutzfeldt-Jakob Disease (CJD) agent. There could also be other infectious agents some of which may not yet have been discovered.

To reduce the risk of this happening, extra steps are taken when manufacturing this product. Strict controls are applied when selecting blood donors and donations. The product is specially treated to remove and kill certain viruses. This special treatment is considered effective against viruses known as enveloped viruses such as HIV and hepatitis B and C viruses, and the non-enveloped virus, hepatitis A. These procedures may be of limited value against the non-enveloped virus, parvovirus B19. However, the product contains specific antibodies directed against parvovirus B19. Parvovirus B19 is a virus causing respiratory irritation, commonly affecting children.

Despite the measures taken, the risk of viral and other agents’ infectivity cannot be totally eliminated.

Vaccines are available against some of these viruses and your doctor will be able to help you decide whether it is worthwhile having any of those vaccines.

Please discuss the risks and benefits of this product with your doctor.

Back to top

Interference with glucose estimations

The maltose present in Intragam® P may interfere with some blood glucose measurements, resulting in the overestimation of blood glucose results. If this glucose measurement is used to guide treatment, hypoglycaemia may occur. Only certain glucose tests have been implicated, so when monitoring glucose levels consult your doctor to ensure that maltose does not interfere with the blood glucose reading of the test you are using. Infusion of Intragam® P may also result in elevated levels of glucose in the urine for a short period of time.

If you want further information, or if you are worried about any other symptoms after the infusion, consult your doctor.

Back to top


Administering a larger than recommended dose may lead to thickening of the blood and expansion of the blood volume, particularly in elderly patients and patients with kidney problems.

Back to top

Storing Intragam® P

Store at 2°C to 8°C (Refrigerate. Do not freeze). Once removed from refrigeration, store below 25°C and use within 3 months. Protect from light.

Do not use after the expiry date.

Further information

Intragam® P can only be obtained on a doctor’s prescription. This leaflet does not contain the complete information about Intragam® P. If you require further information about Intragam® P and your treatment generally, or if you have any questions or are not sure about something in this leaflet, consult your doctor.

Back to top

Product description

What it looks like

Intragam® P is a clear, colourless, non-viscous (not thick) solution. It is available in glass bottles.


In each vial of Intragam® P is a sterile solution containing 6% blood proteins of which at least 98% is immunoglobulins. It also contains 10% maltose (a sugar).


Intragam® P is manufactured in Australia by:
CSL Behring (Australia) Pty Ltd
ABN 48 160 734 761
189-209 Camp Road
Broadmeadows VIC 3047


Australian Red Cross Blood Service

Date of most recent amendment

August 2014

Australian Register Numbers
10 mL: AUST R 68635
50 mL: AUST R 68632
200 mL: AUST R 68633

® Registered trademark of CSL Limited

Back to top

CMI provided by MIMS Australia, January 2015  

Related information - Intragam P Solution for infusion


04 Apr 2016 Information on medicines available in Australia containing immunoglobulin, normal (human), including our latest evidence-based information and resources for health professionals and consumers. The active ingredient is the chemical in a medicine that makes it work. Medicines that contain the same active ingredient can be available under more than one brand name. Brands include both active ingredients and inactive ingredients. You'll find information about brands of medicines that contain immunoglobulin, normal (human) below, including their consumer medicine information (CMI) leaflets.
02 Nov 2012 Find reliable, independent information about gamma globulin deficiency. You’ll find resources for consumers and health professionals about this health condition and any related treatments, medicines and medical tests.gamma globulin deficiency is also known as hypogammaglobulinaemia.
02 Nov 2012 Find reliable, independent information about immune deficiency. You’ll find resources for consumers and health professionals about this health condition and any related treatments, medicines and medical tests.immune deficiency is also known as immunodeficiency.
02 Nov 2012 Find reliable, independent information about low platelet count of unknown cause. You’ll find resources for consumers and health professionals about this health condition and any related treatments, medicines and medical tests.low platelet count of unknown cause is also known as idiopathic thrombocytopenic purpura and purpura, idiopathic thrombocytopenic.